BMS inks first discovery pact in China; Cornerstone buys EKR in $150M deal;

 @FierceBiotech: Mobile apps could rival pharma's crown jewels. More | Follow @FierceBiotech

 @JohnCFierce: New chief takes helm at Promedior (fibrosis) and steers a course for Boston. More | Follow @JohnCFierce

 @RyanMFierce: Interesting case for why mobile health apps could compete with drugs and hurt pharma by @chasedave. Analysis | Follow @RyanMFierce

> Bristol-Myers Squibb ($BMY) has established its first discovery partnership in China, inking a deal to collaborate with investigators at Tsinghua University on cancer and immunoscience. The collaboration will also focus on "structural biology research, the science of mapping the 3D protein structure of biological molecular targets that could serve as the basis for future drug discovery projects." Release

> Cornerstone Therapeutics has announced a deal to acquire EKR Therapeutics for $150 million. EKR sells acute-care products. Story

> Theraclone says that its antibody treatment for multiple flu strains has demonstrated a clean safety profile in an early-stage study.  Report

> Arno Therapeutics reports that it had gained orphan drug status in Europe for an experimental treatment for neurofibromatosis type 2. Story

Pharma News

 @FiercePharma: Italy's Rovati family finds partners w/cash: Rottapharm sells 50% stake to private equity firms--Bloomberg. Story | Follow @FiercePharma

> Payers likely to throw up hurdles to Pfizer's new RA drug. More

> U.K. officials demand action on worsening drug shortages. Item

> Private equity firms snap up 50% of Rottapharm. Story

> Drugmakers don't have apps for that--yet. Article

Medical Device News

 @FierceMedDev: Folks, the clock is ticking. Get your nominations in for the 15 fiercest device developers. Survey | Follow @FierceMedDev

> Sonitus Medical lands $25 million Series D round for hearing device. More

> After quiet Q4, device recalls surge in 2012. News

> Boston Sci, Abbott gain European sign-off for stent products & services. Story

Biotech Research News

> Scientist uses stem cells to rebuild bone. News

> How do you make a deaf mouse hear? Emory University tries gene therapy. More

> Compounds may combat cancers by reversing p53 mutation. Article

Pharma Manufacturing News

> U.K. pharmacy group wants drug exports stopped. Story

> Merck KGaA says cuts will save $385 million. News

> Pakistan's ephedrine scandal takes on international intrigue. Article

And Finally… A new study indicates that 53 million Americans could be diagnosed with diabetes by 2025, a 64% increase over 2010 numbers. Release

 

Suggested Articles

The suit alleges the FDA imposed the hold “without notice or explanation” and has since “rebuffed” Regenxbio’s repeated requests for an explanation.

Bolt Biotherapeutics presented positive results from animal trials of its lead drug, a tumor-targeting antibody connected to an immune stimulator.

Gilead presented studies at AASLD showing how noninvasive testing and machine learning could improve diagnostics and drug development for NASH.